Armando Castro, partner, emerging companies, venture capital, Lowenstein Sandler, explains how repurposing GLP-1s and ...

Weight-loss and diabetes drugs dominated pharmaceutical spending last year, according to a new report by the American Society ...

The order pushes drug companies to reduce drug prices in the United States to fall in line with other countries around the ...

A successful M&A outcome is contingent upon a deep understanding of the regulatory and scientific fundamentals that underpin ...

Identifying the priorities that translate to strong business outcomes—and separating the top performers from the average ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

On Sunday, President Trump posted to Truth Social that he planned on implementing a most-favored-nation policy for ...

Proposed cuts to Medicaid will have significant impacts on the health industry. One area that will be heavily impacted by ...

The Avmapki Fakzynja Co-Pack marks the first FDA-approved treatment for adult patients with KRAS-mutated recurrent low-grade ...

Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.

Country is poised to offer growth-channel opportunities for global pharma companies ready to scale access, innovation, and ...

The idea of creating a gray zone in the payer message is to take the onus off of having to heavily discount for equal access ...